rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ATR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Aptar: 3 Key Takeaways for Long-Term Investors
      Nov 2Yahoo FinanceATR
      Aptar Q3 2026 slides: broad growth, strong Pharma pipeline
      Nov 1Investing.comATR
      Aptar (ATR) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Oct 31The Globe and MailATR
      Aptar Reports Third Quarter 2026 Results
      Oct 29MorningstarATR
      Aptar Increases Quarterly Dividend to $0.50 Per Share

      CRYSTAL LAKE, Ill., October 29, 2026--Aptar Increases Quarterly Dividend to $0.50 Per Share

      Oct 29Yahoo FinanceATR
      Stevanato Group partners with Aptar for syringe testing
      Oct 27Investing.comATRSTVN
      Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
      Oct 27MorningstarATR
      Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection
      Oct 27Yahoo FinanceATR
      Aptar Pharma acquires Pulmotree to expand inhaler portfolio
      Oct 26Investing.comATR
      Aptar Pharma Acquires Pulmotree, Expanding Growth Opportunities in Next-Generation Pulmonary Drug Delivery

      Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced the strategic acquisition of PULMOTREE, a Munich, Germany- based life science company specializing in pulmonary drug delivery systems for targeted delivery to the lungs. "The acquisition of PULMOTREE is an important step in expanding Aptar Pharma’ s...

      Oct 26NasdaqATR
      Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business – Company Announcement
      Oct 22Financial TimesATR
      Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business
      Oct 22MorningstarATR
      Aptar Pharma receives CE mark for intranasal vaccine device
      Oct 14Investing.comATR
      Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers – Company Announcement - FT.com
      Oct 14Financial TimesATR
      Aptar partners with MGH on nose-to-brain drug delivery research
      Sep 14Investing.comATR
      Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

      CRYSTAL LAKE, Ill., September 14, 2026--Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

      Sep 14Yahoo FinanceABOSATR
      Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance

      Aptar's ACT-101 is designed to intervene a step earlier than current CF modulators.

      Sep 7Yahoo FinanceATR
      Aptar Beauty powers L’Occitane’s transition to refillable bottles

      The custom pump has a 24/410 screw-on neck finish, with the actuator and collar enlarged to fit the broader bottle shape.

      Aug 27Yahoo FinanceATR

      This is the newest page. Registered accounts read further back.